Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-04-24
1980-11-25
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, G01N 3316, A61K 4300
Patent
active
042358671
ABSTRACT:
Disclosed is a polymer matrix based on a copolymer of acrylamide to immobilize antibodies in the radioimmunological determination of hormones and the pharmaceuticals. The specific copolymers are formed by polymerization of acrylamide and one or more copolymerizable compounds such as acrylic acid, methacrylic acid, methacrylamide, their derivatives and salts of acrylic acid or methacrylic acid.
REFERENCES:
patent: 4061466 (1977-12-01), Sjoholm et al.
Goodfriend et al., Immuno Chemistry, vol. 6, May, 1969, pp. 481-484.
Chandon Investment Planning Ltd.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Acrylamide copolymer matrix for radioimmune assay techniques does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acrylamide copolymer matrix for radioimmune assay techniques, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acrylamide copolymer matrix for radioimmune assay techniques will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1129636